(INOD) Innodata - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4576422053
INOD: AI Data Services, Healthcare Solutions, Media Monitoring Tools
Innodata Inc. (NASDAQ:INOD) is a data engineering company specializing in AI-driven solutions, operating across the U.S., U.K., Netherlands, Canada, and other international markets. The firm is organized into three core segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment focuses on AI data preparation, including training data collection, annotation, and model deployment, alongside data engineering services such as transformation, curation, and compliance. The Synodex segment leverages proprietary data models to convert medical records into actionable digital data, addressing healthcare and life sciences sectors. The Agility segment provides a platform for marketing and PR professionals to distribute content, monitor news, and analyze media channels, serving industries like banking, insurance, and technology.
The company, formerly known as Innodata Isogen, Inc., rebranded in 2012 and is headquartered in Ridgefield Park, New Jersey. It delivers solutions through a combination of professional staff, senior management, and direct sales teams, targeting sectors such as financial services, digital retail, and media. With a market capitalization of $1.246 billion and a price-to-earnings ratio of 44.10, Innodata operates in the data processing and outsourced services industry, listed under the NASDAQ exchange.
3-Month Forecast: - Month 1: Price expected to test resistance at 40.3, with potential pullback to support at 37.4. SMA 20 (35.37) and SMA 50 (41.90) indicate a narrowing range, suggesting volatility reduction. ATR (3.60) signals moderate price movement. - Month 2: Break above 40.3 could target 45.6 resistance, with SMA 50 potentially crossing above SMA 200 (31.80), signaling bullish momentum. Support at 37.4 may hold if tested. - Month 3: If resistance at 45.6 is breached, upside could extend toward 50.0. Alternatively, failure at 45.6 may lead to retracement toward 40.3, with support at 37.4 acting as a floor.Additional Sources for INOD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
INOD Stock Overview
Market Cap in USD | 1,228m |
Sector | Technology |
Industry | Information Technology Services |
GiC Sub-Industry | Data Processing & Outsourced Services |
IPO / Inception | 1993-08-10 |
INOD Stock Ratings
Growth Rating | 84.1 |
Fundamental | 82.0 |
Dividend Rating | 0.0 |
Rel. Strength | 267 |
Analysts | 4.5/5 |
Fair Price Momentum | 45.32 USD |
Fair Price DCF | 5.27 USD |
INOD Dividends
No Dividends PaidINOD Growth Ratios
Growth Correlation 3m | -76.5% |
Growth Correlation 12m | 80.7% |
Growth Correlation 5y | 75.1% |
CAGR 5y | 108.91% |
CAGR/Max DD 5y | 1.46 |
Sharpe Ratio 12m | 0.42 |
Alpha | 260.46 |
Beta | 4.341 |
Volatility | 113.00% |
Current Volume | 4657.8k |
Average Volume 20d | 1061.7k |
As of May 09, 2025, the stock is trading at USD 41.11 with a total of 4,657,837 shares traded.
Over the past week, the price has changed by +4.74%, over one month by +28.11%, over three months by -7.26% and over the past year by +292.65%.
Yes, based on ValueRay Fundamental Analyses, Innodata (NASDAQ:INOD) is currently (May 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 82.04 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INOD as of May 2025 is 45.32. This means that INOD is currently undervalued and has a potential upside of +10.24% (Margin of Safety).
Innodata has received a consensus analysts rating of 4.50. Therefor, it is recommend to buy INOD.
- Strong Buy: 2
- Buy: 2
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, INOD Innodata will be worth about 54.4 in May 2026. The stock is currently trading at 41.11. This means that the stock has a potential upside of +32.3%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 70.2 | 70.8% |
Analysts Target Price | 46.3 | 12.7% |
ValueRay Target Price | 54.4 | 32.3% |